Novo Nordisk to launch anti-obesity drug in India
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Diabetes care company Novo Nordisk will launch an anti-obesity drug, Saxenda in India after receiving necessary approvals. Patients with high blood sugar can also take this drug. The product received its first regulatory approval in September 2012 and has since been approved in more than 80 countries and is now commercially available in more than 50 countries...


http://bit.ly/2tHSRup
Like
Comment
Share